The PD-1 Inhibitors Segment is Expected to Hold the Largest Market Share in the Immune Checkpoint Inhibitors Market Thus, the rise in the volume of patient pool, increased awareness among the people along with earlier detection of cancer using technologically advanced screening procedures are likely to boost the immune checkpoint inhibitors market's growth during the forecast period. The primary factor attributing to the growth of the market is a steep rise in the global prevalence of various types of cancers coupled with a steep increase in the geriatric population across the geographical locations, mainly in developed and emerging economies.įor instance, according to the World Health Organization report, cancer is a leading cause of mortality globally, accounting for an estimated 9.6 million deaths, and lung cancer was identified as the most common cause of death, with 1.76 million deaths in 2018. The immune checkpoint inhibitors market studied was anticipated to grow with a CAGR of 18% during the forecast period. 30, 2020 (GLOBE NEWSWIRE) - The "Immune Checkpoint Inhibitors Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to 's offering.
0 kommentar(er)
